Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1940058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Vijay Singh Gondil und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States. Hauptthemen laut MEDLINE: Penicillin-Binding Proteins, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Staphylococcus aureus penicillin-binding protein 4 (PBP4) is a non-essential, low-molecular-weight transpeptidase that contributes to peptidoglycan maintenance under conventional laboratory growth conditions. Several recent studies have suggested that the protein’s cellular functions have far-reaching consequences, directly affecting S. aureus success as a human pathogen. Herein, we review recent work implicating PBP4 as a modulator of a noncanonical PBP2A-independent methicillin-resistant S. aureus (MRSA) phenotype that extends to the most recently developed fifth-generation cephalosporins. Furthermore, we review emerging studies indicating that PBP4 is a previously unappreciated virulence factor that governs an essential step in osteomyelitis pathogenesis, namely the invasion of osteocyte lacuna-canalicular networks (OLCNs). Given the protein’s involvement in these two disease-related processes, we discuss PBP4’s potential as a non-traditional antimicrobial therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.
- Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States.
Förderung
- NIAMS NIH HHS
Zitieren
APA
Gondil, V. S., Stefaniak, M. A., Melander, C., & Dunman, P. M. (2026). Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1940058
Vancouver
Gondil VS, Stefaniak MA, Melander C, Dunman PM. Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1940058
BibTeX
@article{Gondil2026,
author = {Gondil, Vijay Singh and Stefaniak, Monica A and Melander, Christian and Dunman, Paul M},
title = {Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1940058}
}
EUVIMED